Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TSMC | 7.79% | $390.06K | $1.55T | 91.36% | 81 Outperform | |
| AstraZeneca | 6.04% | $302.58K | $306.87B | 22.83% | 80 Outperform | |
| HOYA | 5.78% | $289.45K | ¥9.50T | 48.00% | 74 Outperform | |
| ASML Holding NV | 5.73% | $286.86K | €453.03B | 72.70% | 76 Outperform | |
| Prudential | 4.74% | $237.45K | £27.44B | 45.01% | 71 Outperform | |
| AIA Group | 4.54% | $227.62K | HK$894.25B | 29.17% | 72 Outperform | |
| SAFRAN SA | 4.32% | $216.66K | €131.87B | 22.00% | 67 Neutral | |
| British American Tobacco | 4.23% | $211.89K | £95.15B | 41.87% | 71 Outperform | |
| Linde | 4.22% | $211.35K | $227.09B | 4.54% | 66 Neutral | |
| Alibaba Group Holding Ltd. | 4.20% | $210.53K | HK$2.12T | -6.64% | 70 Outperform |